Pure Global

Multiple congenital aneuploidy screening IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Multiple congenital aneuploidy screening IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 100009. The device is manufactured by Natera, Inc from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Qarad UK Ltd..

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Multiple congenital aneuploidy screening IVD, kit, nucleic acid technique (NAT)
MHRA Device ID: 100009โ€ขRef: 100009

Device Type

In Vitro Diagnostic Device

Devices

Multiple congenital aneuploidy screening IVD, kit, nucleic acid technique (NAT)

Type

IVD Annex II List B

Date Registered

Nov 26, 2024

Last Updated

Jul 2, 2024

Manufacturer Information

Address

201 Industrial Road, Suite 410

San Carlos, California, United States

Created Date

Aug 27, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

8 Northumberland Ave

Westminster, London , England, United Kingdom

Postcode: WC2N 5BY

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing